Quest Diagnostics

Established in 1971, Laboratory Corporation of America Holdings is a publicly traded company that specializes in blood analysis and drug and genomic testing services. The company operates a network of more than 35 primary testing locations and over 1,600 patient service centers in the United States. It offers forensic, ambulatory monitoring, DNA identification and bone marrow services. The company also provides laboratory services that assist in the fields of anatomic pathology, cardiology, dermatology, endocrinology and gastroenterology. Laboratory Corporation of America Holdings conducts clinical trial testing solutions through its Esoterix Clinical Trials Services division. In addition, it operates The Center for Esoteric Testing, National Genetics Institute, ViroMed Laboratories, Litholink Corporation and DIANON Systems. Laboratory Corporation of America Holdings performs approximately 1 million tests on nearly 400,000 samples each day. The company serves hospitals, government agencies, clinical labs, pharmaceutical companies and managed care organizations. As one of the world s largest clinical laboratories, it works in partnership with several community-based organizations, such as the United Way, March of Dimes, American Cancer Society, and Juvenile Diabetes Research Foundation. Laboratory Corporation of America Holdings has annual revenues of more than $4.5 billion.

BioAgilytix Labs in Durham, NC is a trusted partner for biopharma organizations, offering unparalleled expertise in bioanalysis throughout the drug development process. With over 30 years of experience, the company specializes in demanding areas requiring advanced scientific skills and exceptional service standards. The company excels in method transfer practices for maintaining assay performance, customized assay development tailored to regulatory requirements, accurate sample analysis during preclinical and clinical testing, and production of clinical trial specimen collection kits. BioAgilytix also provides specialized diagnostic testing services with expedient analysis and customized reporting. Utilizing off-the-shelf assays for faster timelines and reduced costs, BioAgilytix fosters a scientist-to-scientist approach, minimizing risks and ensuring therapeutic advancements reach the market efficiently. The company's industry-leading capabilities, regulatory track record, and focus on quality guarantee effective project management and successful bioanalytical services. Generated from the website content